Form 4 for ELV Elevance Health
Accepted 2023-12-01 00:00:00 ET · period of report 2023-11-30 · accession 0001156039-23-000118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-01 | 2023-11-30 | ELV | Penczek Ronald W | CAO, Ctrl | S - Sale | $475.17 | -1,055 | 1,787 | -37% | -$501.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-30 | S | D | 1,055 | $475.17 | 1,787 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $475.05 to $475.23. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |